Biopharmaceutical PAT market forecast to reach $4.32bn

shutterstock_2685943461

Growing demand for real-time process monitoring and more consistent biopharmaceutical manufacturing is expected to drive investment in process analytical technology.

The global biopharmaceutical process analytical technology (PAT) market is forecast to reach $4.32 billion by 2031, according to a market report published by MarketsandMarkets on 28 July.

The commercial market forecast points to increasing adoption of analytical systems that allow manufacturers to measure and control production processes as they take place…

 

Already a member? Sign-in

Unlock

Driving innovation in pharma manufacturing

European Pharmaceutical Review delivers authoritative insights, cutting-edge innovations, and expert perspectives that not only inform decisions but drive measurable progress across quality, compliance, and operational excellence.

Become a member to continue reading

By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:

  • Unlimited access to industry intelligence that can make a difference to your business
  • A weekly newsletter keeping the most vital information at the front of your thinking
  • Exclusive invitations to powerful webinars and events featuring high profile experts
  • Access to deep-dive reports and analysis that reveal exciting new opportunities for business growth and transformation

Become a member